A detailed history of Nicolet Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nicolet Advisory Services, LLC holds 11,222 shares of ABBV stock, worth $2.02 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
11,222
Previous 11,351 1.14%
Holding current value
$2.02 Million
Previous $1.95 Million 13.87%
% of portfolio
0.21%
Previous 0.19%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $21,135 - $25,713
-129 Reduced 1.14%
11,222 $2.22 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $38,852 - $45,370
251 Added 2.26%
11,351 $1.95 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $193,701 - $220,705
1,212 Added 12.26%
11,100 $2.02 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $1,788 - $2,014
-13 Reduced 0.13%
9,888 $1.53 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $98,455 - $113,977
737 Added 8.04%
9,901 $1.48 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $54,461 - $67,773
411 Added 4.7%
9,164 $1.23 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $70,569 - $81,271
488 Added 5.9%
8,753 $1.39 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $419,217 - $502,751
3,031 Added 57.91%
8,265 $1.34 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.06%
5,234 $724,000
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $17,340 - $22,044
126 Added 2.47%
5,237 $796,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $9,238 - $11,462
70 Added 1.39%
5,111 $894,000
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $293,391 - $371,224
-2,731 Reduced 35.14%
5,041 $683,000
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $162,579 - $184,551
1,528 Added 24.47%
7,772 $840,000
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $50,921 - $56,729
-484 Reduced 7.19%
6,244 $703,000
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $24,245 - $26,690
-237 Reduced 3.4%
6,728 $728,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $56,986 - $76,938
708 Added 11.32%
6,965 $746,000
Q3 2020

Oct 27, 2020

SELL
$85.91 - $100.83 $153,349 - $179,981
-1,785 Reduced 22.2%
6,257 $548,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $21,497 - $28,766
293 Added 3.78%
8,042 $790,000
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $130,354 - $197,633
2,021 Added 35.28%
7,749 $590,000
Q4 2019

Jan 23, 2020

SELL
$72.13 - $90.25 $26,904 - $33,663
-373 Reduced 6.11%
5,728 $507,000
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $58,571 - $70,419
930 Added 17.98%
6,101 $462,000
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $919 - $1,175
14 Added 0.27%
5,171 $376,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $397,810 - $468,204
5,157 New
5,157 $416,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.